Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
doi.org/10.1038/s41598-020-73429-x
The researchers suggest that tirzepatide could be used to reduce the risk of heart and circulatory diseases that are caused by obesity by helping people lose more weight
Clinicians will also evaluate a patient for medical conditions that might make weight loss more challenging, such as perimenopause or hypothyroidism, which is underactive thyroid
A 2022 study published in JAMA Network Open found that people taking antidepressants experienced somewhat reduced weight loss with GLP-1 medications compared to those not taking antidepressants
Ships directly to the USA
US$ 29.65
US$ 24.44
US$ 29.68
US$ 26.15
